title: Cost-opportunity analysis in clinical oncology: from the 'wild far-west' to a correct integration of the disciplines, avoiding the 'war of the worlds'.
authors.forename: D
authors.initials: D
authors.lastname: Tassinari
authors.forename: B
authors.initials: B
authors.lastname: Poggi
authors.forename: M
authors.initials: M
authors.lastname: Fantini
authors.forename: E
authors.initials: E
authors.lastname: Tamburini
authors.forename: S
authors.initials: S
authors.lastname: Nicoletti
authors.forename: S
authors.initials: S
authors.lastname: Sartori
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000191:economics; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics; D010166:Palliative Care